Published • loading... • Updated
Compounded GLP-1 Drugs Creating Concern Among Doctors and FDA
The FDA said 25 warning letters target misleading ads as compounded versions lack the safety and manufacturing oversight of approved drugs.
- The FDA issued 25 warning letters to telehealth companies last month, targeting what the agency characterized as deceptive marketing of compounded GLP-1 medications.
- Compounded versions lack the manufacturing consistency of FDA-approved GLP-1 drugs, prompting regulators to advise patients obtain prescriptions from doctors and use licensed pharmacies.
- Stanford Medicine's Michael Blyumin notes patients often seek compounded drugs due to cost concerns, warning, "But I advise against it; there are a lot of potential problems."
- Reality star Kendra Wilkinson, 41, recently celebrated her weight-loss journey on Instagram, posting, "Omg I've lost so much weight LOL."
- Existing patent rights are projected to block generic GLP-1 alternatives from reaching Americans until 2032, even as brand-name FDA-approved GLP-1 drugs cost over $1,000 monthly.
Insights by Ground AI
11 Articles
11 Articles
Kendra Wilkinson Flaunts Bikini Body Amid GLP-1 Weight Loss Journey: ‘I Feel So Good’
Kendra Wilkinson is showing off the results of her GLP-1 weight loss journey. “I feel so good in my body right now,” the reality star, 41, wrote via Instagram on Tuesday, July 28. “Like actual summer ready, not the fake kind. And a big part of that has been GLP1s done right.” Wilkinson shared a […]
·Englewood Cliffs, United States
Read Full Article
Coverage Details
Total News Sources11
Leaning Left1Leaning Right1Center6Last UpdatedBias Distribution75% Center
Bias Distribution
- 75% of the sources are Center
75% Center
13%
C 75%
12%
Factuality
To view factuality data please Upgrade to Premium
